ArticleGigaScience2024
Protein-protein and protein-nucleic acid binding site prediction via interpretable hierarchical geometric deep learning.
Article in GigaScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- BiMba: using Vision Mamba to predict protein sites that bind other proteins.Bioinformatics (Oxford, England) · 2026Article
- MPLID (Membrane Protein-Lipid Interaction Database): A Large-Scale Experimental Resource of Residue-Level Protein-Lipid Contacts.GigaScience · 2026Article
- Accurate proteome-wide prediction of enzymes and catalytic sites using graph deep learning and protein language model.GigaScience · 2026Article
- NanoBind: Mechanism-Driven Deep Learning of Nanobody-Antigen Molecular Recognition.Research (Washington, D.C.) · 2026Article
- DTBind: A Mechanism-Driven Deep Learning Framework for Accurate Prediction of Drug-Target Molecular Recognition.Research (Washington, D.C.) · 2025Article
- Protein-protein and protein-nucleic acid binding site prediction via interpretable hierarchical geometric deep learning.GigaScience · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Identification of protein-protein and protein-nucleic acid binding sites provides insights into biological processes related to protein functions and technical guidance for disease diagnosis and drug design. However, accurate predictions by computational approaches remain highly challenging due to the limited knowledge of residue binding patterns. The binding pattern of a residue should be characterized by the spatial distribution of its neighboring residues combined with their physicochemical information interaction, which yet cannot be achieved by previous methods. Here, we design GraphRBF, a hierarchical geometric deep learning model to learn residue binding patterns from big data. To achieve it, GraphRBF describes physicochemical information interactions by designing an enhanced graph neural network and characterizes residue spatial distributions by introducing a prioritized radial basis function neural network. After training and testing, GraphRBF shows great improvements over existing state-of-the-art methods and strong interpretability of its learned representations. Applying GraphRBF to the SARS-CoV-2 omicron spike protein, it successfully identifies known epitopes of the protein. Moreover, it predicts multiple potential binding regions for new nanobodies or even new drugs with strong evidence. A user-friendly online server for GraphRBF is freely available at http://liulab.top/GraphRBF/server.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.